Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 6.80 MYR
Change Today +0.08 / 1.19%
Volume 113.7K
As of 4:35 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

pharmaniaga berhad (PHRM) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/28/15 - 7.53
52 Week Low
12/15/14 - 4.10
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for PHARMANIAGA BERHAD (PHRM)

Related News

No related news articles were found.

pharmaniaga berhad (PHRM) Related Businessweek News

No Related Businessweek News Found

pharmaniaga berhad (PHRM) Details

Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare company in Malaysia and Indonesia. It operates through Logistics and Distribution, and Manufacturing segments. The company is involved in the manufacture and sale of generic pharmaceutical products; trading and wholesale of consumer products; supply, trading, and installation of medical and hospital equipment; and distribution and trading of pharmaceutical products, medical products, food supplements, and diagnostic products. It also engages in the research and development of pharmaceutical products. The company is based in Shah Alam, Malaysia. Pharmaniaga Berhad is a subsidiary of Boustead Holdings Berhad.

2,972 Employees
Last Reported Date: 03/9/15

pharmaniaga berhad (PHRM) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

pharmaniaga berhad (PHRM) Key Developments

Pharmaniaga Bhd Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015

Pharmaniaga Bhd announced unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported profit attributable to owners of parent of MYR 31,794,000 or 12.28 sen basic and diluted earnings per share on revenue of MYR 471,904,000 compared to profit attributable to owners of parent of MYR 26,217,000 or 10.13 sen basic and diluted earnings per share on revenue of MYR 468,672,000 of prior year period. Profit before taxation was MYR 38,612,000 against MYR 38,159,000 of prior year period. Net cash used in operating activities was MYR 125,475,000 against MYR 7,359,000 of prior year period. Purchase of property, plant and equipment was MYR 3,787,000 against MYR 7,149,000 of prior year period. Purchase of intangible assets was MYR 2,533,000 against MYR 194,000 of prior year period. The improved profit before tax was primarily attributable to higher profit margins from Manufacturing Division as a result of improved operational efficiencies which has directly reduced its manufacturing costs.

Pharmaniaga Bhd Declares Single Tier First Interim Dividend, Payable on June 25, 2015

Pharmaniaga Bhd declared single tier first interim dividend of 7 sen per share for the year ending December 31, 2015. The ex dividend date for the dividend is June 1, 2015 and payment date is June 25, 2015.

Pharmaniaga Mulls Acquisitions

Pharmaniaga Bhd (KLSE:PHARMA) is seeking acquisitions. Chairman Tan Sri Lodin Wok Kamaruddin said, "We're open to new opportunities for growth, be it via acquisitions or organically, in order to enhance our core business."


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PHRM:MK 6.80 MYR +0.08

PHRM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PHRM.
View Industry Companies

Industry Analysis


Industry Average

Valuation PHRM Industry Range
Price/Earnings 17.0x
Price/Sales 0.8x
Price/Book 3.2x
Price/Cash Flow 15.2x
TEV/Sales 0.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMANIAGA BERHAD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at